BioCentury
ARTICLE | Company News

Areva Med, Roche to develop cancer radioimmunotherapy

July 28, 2012 12:48 AM UTC

Areva Med LLC (Bethesda, Md.) partnered with Roche (SIX:ROG; OTCQX:RHHBY) to develop an alpha radioimmunotherapy platform to treat cancer. Roche's Pharma Research & Early Development organization (pRE...